Amara, Nelly <br/><br/>
Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.  [electronic resource] 

 -  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology  01 2018 
 - 65-72 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1532-2092 
<br/><br/><label>Standard No.: </label>10.1093/europace/euw379  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Cardiomyopathies--diagnosis<br/>Cause of Death<br/>Death, Sudden, Cardiac--epidemiology<br/>Defibrillators, Implantable<br/>Electric Countershock--adverse effects<br/>Female<br/>France--epidemiology<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Myocardial Ischemia--diagnosis<br/>Primary Prevention--instrumentation<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome